Completed OBSERVATIONAL NCT00749970

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia (SWN-K)

Sponsor: AstraZeneca

Conditions Schizoaffective Disorder Schizophrenia Schizophreniform Disorder

Updated 7 times since 2017 Last updated: Dec 8, 2010 Started: Jul 31, 2008 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Schizoaffective Disorder and Schizophrenia and is currently completed. AstraZeneca leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AstraZeneca

Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alicante, Spain , Barcelona, Spain , Burgos, Spain , Córdoba, Spain , Granada, Spain , Madrid, Spain , Mallorca, Spain , Salamanca, Spain , Seville, Spain , Tarragona, Spain and 4 more locations